Cite Filings / FDMT / 9999999995-26-001626

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

4D Molecular Therapeutics, Inc. Filed 2026-05-13 Acc 9999999995-26-001626

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-13 EFFECT Notice of Effectiveness
2026-05-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-11 CORRESP Correspondence Between Filers and SEC Staff
2026-05-08 UPLOAD SEC-generated Letter
2025-03-24 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…